Product Information
HUMALOG MIX 75-25 KWIKPEN is a brand product labeled by Eli Lilly and Company, priced at $10.1667 per ML under NDC 00002879759. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002879759
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA021017On Market Since
9/6/2007
Pharmacological Classes
Price Statistics
The NADAC for HUMALOG MIX 75-25 KWIKPEN has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 47.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1667 per ML |
|---|---|
| All-time high | $34.2085 (Jun 14, 2017) |
| All-time low | $10.1667 (Aug 20, 2025) |
| 52-week high | $10.1743 |
| 52-week low | $10.1667 |
| Median price | $33.8893 |
| Average price | $27.0023 |
| Largest weekly change | -70.0% (Jan 10, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Insulin lispro market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HUMALOG MIX 75-25 KWIKPEN?
The current National Average Drug Acquisition Cost (NADAC) for HUMALOG MIX 75-25 KWIKPEN, manufactured by Eli Lilly and Company, is $10.1667 per ML (NDC 00002879759), effective Sep 30, 2026.
How has the price of HUMALOG MIX 75-25 KWIKPEN changed over time?
Over the history we have for it, the NADAC for HUMALOG MIX 75-25 KWIKPEN has declined 47.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HUMALOG MIX 75-25 KWIKPEN?
Since Nov 28, 2013, the NADAC for HUMALOG MIX 75-25 KWIKPEN has ranged from a low of $10.1667 (Aug 20, 2025) to a high of $34.2085 (Jun 14, 2017), with a median of $33.8893 per ML.
Are there cheaper alternatives to HUMALOG MIX 75-25 KWIKPEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INSULIN LISPRO 100 UNIT/ML VL, is $2.4026 per ML — about 76% below HUMALOG MIX 75-25 KWIKPEN.
Who manufactures HUMALOG MIX 75-25 KWIKPEN?
HUMALOG MIX 75-25 KWIKPEN (NDC 00002879759) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.